FDA Adverse Event Injury Summary report: N

XACT CAROTID STENT SYSTEM

MDR report key: 1051054 · Received May 22, 2008

Report

Report Number
9616695-2008-00080
Event Type
Injury
Date Received
May 22, 2008
Date of Event
April 22, 2008
Report Date
April 28, 2008
Manufacturer
ABBOTT VASCULAR GALWAY
Product Code
NIM
PMA / PMN Number
P040038
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE STENT REMAINS IN THE PATIENT. THE LOT NUMBER WAS PROVIDED. NEUROLOGICAL COMPLICATION IS A KNOWN POSSIBLE ADVERSE EVENT ASSOCIATED WITH THE USE OF CAROTID STENTS AS STATED IN THE XACT INSTRUCTIONS FOR USE. NO DEVICE MALFUNCTION WAS REPORTED. A REVIEW OF THE FINISHED DEVICE LOT HISTORY RECORD DID NOT REVEAL ANY NON-CONFORMITIES WHICH COULD HAVE CONTRIBUTED TO THIS COMPLAINT.

Description of Event or Problem · 1

MALFUNCTION: NONE. SYMPTOMS/AE: NEUROLOGICAL EVENT - ETIOLOGY UNKNOWN. TIME OF SYMPTOMS: THIRTEEN DAYS POST PROCEDURE. IT WAS REPORTED THAT APPROXIMATELY 13 DAYS POST AN UNEVENTFUL LEFT INTERNAL CAROTID ARTERY (LICA) STENTING PROCEDURE, THE PATIENT HAD COMPLAINTS OF WEAKNESS, IMPAIRED SPEECH (SLOW BUT CLEAR) AND DIFFICULTY AMBULATING. SIXTEEN DAYS POST PROCEDURE, THE PATIENT WAS ADMITTED TO THE HOSPITAL. THE ETIOLOGY OF THE SYMPTOMS REMAIN UNCLEAR AS THE PATIENT HAS ALZHEIMER'S WITH DEMENTIA AND PRESENTED TO THE HOSPITAL WITH HYPERCALCEMIA. A HEAD CT WAS NEGATIVE AND AN MRI SHOWED ONLY MILD CHRONIC SMALL VESSEL ISCHEMIC CHANGES. TWENTY SIX DAYS POST PROCEDURE, THE SYMPTOMS AND THE HYPERCALCEMIA RESOLVED AND THE PATIENT WAS DISCHARGED BACK TO THE NURSING FACILITY SHE CAME FROM. ALTHOUGH REQUESTED, THERE IS NO ADDITIONAL INFORMATION AVAILABLE. STUDY EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XACT CAROTID STENT SYSTEM NIM ABBOTT VASCULAR GALWAY NA 444727

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization EMBOSHIELD EMBOLIC PROTECTION DEVICE| HEPARIN